Berita Kesehatan
Inhaled corticosteroids for outpatients with Covid-19: a meta-analysis
Senin, 14 Feb 2022 14:55:00

Todd C. Lee, Émilie Bortolussi-Courval, Sara Belga, Nick Daneman, Adrienne K. Chan, Ryan Hanula, Nicole Ezer, Emily G. McDonald

European Respiratory Journal 2022; DOI: 10.1183/13993003.02921-2021


This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Todd C. Lee reports grants or contracts from Fonds de Recherche Quebec – Sante, Canadian Institutes of Health Research, and McGill Interdisciplinary Institute Infection and Immunity, outside the submitted work.

Conflict of interest: Sara Belga reports grants or contracts from Vancouver Coastal Health Research Institute and Transplant Research Foundation of BC, outside the submitted work.

Conflict of interest: Emily McDonald reports that the study drug for the CONTAIN trial, which is one study in this meta-analysis was donated to our team by COVID pharmaceuticals.

Conflict of interest: Nicole Ezer reports grants or contracts from Fonds de Recherche du Québec en Santé, Rossy Cancer Network, Canadian Institute of Health Research, and MEDTEQ, outside the submitted work. Consulting fees received from Glaxo Smith Kline and Astra Zeneca, outside the submitted work. Receipt of equipment, materials, drugs, medical writing, gifts or other services from COVIS Pharma; Study drug donation for CONTAIN trial (unrestricted).

This is a PDF-only article. Please click on the PDF link above to read it.

  • Received November 15, 2021.
  • Accepted February 1, 2022.